Tubular Urate Transporter Gene Polymorphisms Differentiate Patients with Gout Who Have Normal and Decreased Urinary Uric Acid Excretion

Objective. Primary gout has been associated with single-nucleotide polymorphisms (SNP) in several tubular urate transporter genes. No study has assessed the association of reabsorption and secretion urate transporter gene SNP with gout in a single cohort of documented primary patients with gout carefully subclassified as normoexcretors or underexcretors. Methods. Three reabsorption SNP (SLC22A12/URAT1, SLC2A9/GLUT9, and SLC22A11/OAT4) and 2 secretion transporter SNP (SLC17A1/NPT1 and ABCG2/BRCP) were studied in 104 patients with primary gout and in 300 control subjects. The patients were subclassified into normoexcretors and underexcretors according to their serum and 24-h urinary uric acid levels under strict conditions of dietary control. Results. Compared with control subjects, patients with gout showed different allele distributions of the 5 SNP analyzed. However, the diagnosis of underexcretor was only positively associated with the presence of the T allele of URAT1 rs11231825, the G allele of GLUT9 rs16890979, and the A allele of ABCG2 rs2231142. The association of the A allele of ABCG2 rs2231142 in normoexcretors was 10 times higher than in underexcretors. The C allele of NPT1 rs1165196 was only significantly associated with gout in patients with normal uric acid excretion. Conclusion. Gout with uric acid underexcretion is associated with transporter gene SNP related mainly to tubular reabsorption, whereas uric acid normoexcretion is associated only with tubular secretion SNP. This finding supports the concept of distinctive mechanisms to account for hyperuricemia in patients with gout with reduced or normal uric acid excretion.

[1]  A. Oliveras,et al.  Hipertensión arterial resistente , 2013 .

[2]  杜昕,et al.  Resistant hypertension , 2013 .

[3]  T. Merriman,et al.  Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load , 2013, Annals of the rheumatic diseases.

[4]  Fabian J Theis,et al.  Genome-wide association analyses identify 18 new loci associated with serum urate concentrations , 2012, Nature Genetics.

[5]  J. Ruiz-Galiana,et al.  Uricemia y síndrome metabólico en pacientes con hipertensión arterial , 2012 .

[6]  Y. Moriyama,et al.  A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. , 2012, American journal of physiology. Cell physiology.

[7]  T. Merriman,et al.  The renal urate transporter SLC17A1 locus: confirmation of association with gout , 2012, Arthritis Research & Therapy.

[8]  Chaeyoung Lee,et al.  Genetic architecture for susceptibility to gout in the KARE cohort study , 2012, Journal of Human Genetics.

[9]  J. Banegas,et al.  Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders. , 2012, Metabolism: clinical and experimental.

[10]  M. Lipkowitz.  Regulation of Uric Acid Excretion by the Kidney , 2012, Current Rheumatology Reports.

[11]  T. Nakanishi,et al.  Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2 , 2012, PloS one.

[12]  P. Jutabha,et al.  Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies , 2012, Clinical and Experimental Nephrology.

[13]  Y. Shinohara,et al.  Decreased extra-renal urate excretion is a common cause of hyperuricemia , 2012, Nature Communications.

[14]  A. Marinaki,et al.  Diagnostic Tests for Primary Renal Hypouricemia , 2011, Nucleosides, nucleotides & nucleic acids.

[15]  P. Jutabha,et al.  Urate Transport: Regulators of Serum Urate Levels in Humans , 2011 .

[16]  D. Hernandez,et al.  Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship With Gout and Cardiovascular Disease Risk Factors , 2010, Circulation. Cardiovascular genetics.

[17]  N. Hamajima,et al.  Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population , 2009, Science Translational Medicine.

[18]  T. Merriman,et al.  Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. , 2009, Arthritis and rheumatism.

[19]  Y. Ko,et al.  Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders , 2009, Annals of the rheumatic diseases.

[20]  A. Taniguchi,et al.  Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout , 2009, Annals of the rheumatic diseases.

[21]  E. Boerwinkle,et al.  Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout , 2009, Proceedings of the National Academy of Sciences.

[22]  Christian Gieger,et al.  Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations , 2009, PLoS genetics.

[23]  Gregory Jedd,et al.  A Tether for Woronin Body Inheritance Is Associated with Evolutionary Variation in Organelle Positioning , 2009, PLoS genetics.

[24]  Y. Kikuchi,et al.  Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. , 2008, American journal of human genetics.

[25]  A. Hofman,et al.  Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study , 2008, The Lancet.

[26]  S. Wiedmann,et al.  Association of Common Polymorphisms in GLUT9 Gene with Gout but Not with Coronary Artery Disease in a Large Case-Control Study , 2008, PloS one.

[27]  Olle Melander,et al.  Polymorphisms associated with cholesterol and risk of cardiovascular events. , 2008, The New England journal of medicine.

[28]  F. Russel,et al.  The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. , 2008, Kidney international.

[29]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[30]  T. Dusek,et al.  [Metabolic syndrome in patients with hypertension]. , 2006, Lijecnicki vjesnik.

[31]  M. Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[32]  A. Buño,et al.  The Spectrum of Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Deficiency: Clinical Experience Based on 22 Patients from 18 Spanish Families , 2001, Medicine.

[33]  R. Torres,et al.  A simplified method for the determination of phosphoribosylpyrophosphate synthetase activity in hemolysates. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[34]  D. Mccarty,et al.  Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.

[35]  L. B. Sorensen.  Role of the intestinal tract in the elimination of uric acid. , 1965, Arthritis and rheumatism.

[36]  A. Gutman,et al.  Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. , 1957, The American journal of medicine.

[37]  R. Carey.  Resistant hypertension. , 2013, Hypertension.

[38]  William A. Richardson,et al.  Homozygous SLC2A9 mutations cause severe renal hypouricemia. , 2010, Journal of the American Society of Nephrology : JASN.

[39]  R. Terkeltaub.  Update on gout: new therapeutic strategies and options , 2010, Nature Reviews Rheumatology.

[40]  I. Rudan,et al.  Predictive value of 8 genetic loci for serum uric acid concentration. , 2010, Croatian medical journal.

[41]  J. Graessler,et al.  Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. , 2006, Arthritis and rheumatism.

[42]  P. Conthe Gutiérrez,et al.  Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels. , 1986, Metabolism: clinical and experimental.

[43]  P. Simkin.  Uric acid excretion in patients with gout. , 1979, Arthritis and rheumatism.

[44]  Tom R. Gaunt,et al.  American Journal of Epidemiology Practice of Epidemiology Hardy-weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2022 .